Skip to main content
. Author manuscript; available in PMC: 2009 Aug 5.
Published in final edited form as: Vaccine. 2008 Jun 13;26(33):4150–4159. doi: 10.1016/j.vaccine.2008.05.075

Figure 2. Neurovirulence of modified SLE/DEN4 viruses.

Figure 2

Litters of approximately ten three-day-old Swiss Webster mice were inoculated IC with 102 PFU of indicated virus. Mice were monitored for signs of encephalitis and morbidity for 21 days and the percent survival for each group is indicated. Two virus clones for each modified SLE/DEN4 virus were included in the study.